Paperpal Prime Logo

Translational Neurodegeneration : Impact Factor & More

eISSN: 2047-9158pISSN: 2047-9158
JournalOpen Access

Key Metrics

CiteScore
12
Impact Factor
10 - 15
SJR
Q1Neurology (clinical)
SNIP
1.76
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Translational Neurodegeneration

Translational Neurodegeneration Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher BMC
Language English
Frequency Continuous publication
Article Processing ChargesEUR 2490 | USD 2890 | GBP 2090
Publication Time10
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2012
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 10
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC0
OA statementVisit website
View less

Planning to publish in Translational Neurodegeneration ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Translational Neurodegeneration

Cholesterol nose-to-brain delivery as a possible therapeutic strategy in Huntington\u2019s disease
  • 4 Aug 2026
  • Translational Neurodegeneration
Brain insulin resistance as a driver of proteinopathy in neurodegeneration: from cell-type-specific mechanisms to targeted therapeutics
  • 3 Aug 2026
  • Translational Neurodegeneration
Transaldolase 1 contributes to pentose phosphate pathway disruption and synaptic dysfunction in Alzheimer\u2019s disease
  • 29 Jul 2026
  • Translational Neurodegeneration
Neuroinflammation in Alzheimer\u2019s and Parkinson\u2019s diseases: pathogenic mechanisms and therapeutic strategies
  • 29 Jul 2026
  • Translational Neurodegeneration
Application of the Allen Human Brain Atlas in Alzheimer\u2019s disease and Parkinson\u2019s disease
  • 23 Jul 2026
  • Translational Neurodegeneration
Functional analysis of late-onset Alzheimer\u2019s disease risk genes in Caenorhabditis elegans identifies regulators of neuronal aging
  • 23 Jul 2026
  • Translational Neurodegeneration
Cholesterol nose-to-brain delivery as a possible therapeutic strategy in Huntington\u2019s disease
  • 4 Aug 2026
  • Translational Neurodegeneration
Brain insulin resistance as a driver of proteinopathy in neurodegeneration: from cell-type-specific mechanisms to targeted therapeutics
  • 3 Aug 2026
  • Translational Neurodegeneration
Transaldolase 1 contributes to pentose phosphate pathway disruption and synaptic dysfunction in Alzheimer\u2019s disease
  • 29 Jul 2026
  • Translational Neurodegeneration
Neuroinflammation in Alzheimer\u2019s and Parkinson\u2019s diseases: pathogenic mechanisms and therapeutic strategies
  • 29 Jul 2026
  • Translational Neurodegeneration
Application of the Allen Human Brain Atlas in Alzheimer\u2019s disease and Parkinson\u2019s disease
  • 23 Jul 2026
  • Translational Neurodegeneration
Functional analysis of late-onset Alzheimer\u2019s disease risk genes in Caenorhabditis elegans identifies regulators of neuronal aging
  • 23 Jul 2026
  • Translational Neurodegeneration

FAQs on Translational Neurodegeneration